AGEX THERAPEUTICS, INC. 8-K

Company

Serina Therapeutics, Inc.

Filed

November 14, 2019

Period of Report

November 14, 2019

Accession Number

0001157523-19-002269

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →